Pfizer Inc. (PFE) has announced that the U.S. Food and Drug Administration (FDA) has granted approval for BRAFTOVI (encorafenib) to be used ...
Showing posts with label FDA Grants Accelerated Approval To Pfizer's BRAFTOVI Combination For Metastatic Colorectal Cancer. Show all posts
Showing posts with label FDA Grants Accelerated Approval To Pfizer's BRAFTOVI Combination For Metastatic Colorectal Cancer. Show all posts
Saturday, December 21, 2024
Posts
Posts